Surrogate endpoint evaluation using data from one large global randomized controlled trial

BACKGROUND: Robust identification of surrogate endpoints can help accelerate the development of pharmacotherapies for diseases traditionally evaluated using true endpoints associated with prolonged follow-up. The meta-analysis-based surrogate endpoint evaluation (SEE) integrates data from multiple,...

Descripción completa

Detalles Bibliográficos
Autores principales: Geybels, Milan, Wolthers, Benjamin Ole, Kreiner, Frederik Flindt, Rasmussen, Sren, Bauer, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Technical Advance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139150/
https://www.ncbi.nlm.nih.gov/pubmed/34016120
http://dx.doi.org/10.1186/s12911-021-01516-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139150/
https://www.ncbi.nlm.nih.gov/pubmed/34016120
http://dx.doi.org/10.1186/s12911-021-01516-8

Ejemplares similares